Jiang‐Tao Fu

Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease

Jie Tong, Dongjie Li, Hongbo Meng et al. · Acta Pharmaceutica Sinica B · 2022 · 92 citations · Full text

Exerkine fibronectin type-III domain-containing protein 5/irisin-enriched extracellular vesicles delay vascular ageing by increasing SIRT6 stability

Chen Chi, Hui Fu, Yonghua Li et al. · European Heart Journal · 2022 · 82 citations

NAD⁺-boosting therapy alleviates nonalcoholic fatty liver disease via stimulating a novel exerkine Fndc5/irisin

Dongjie Li, Sijia Sun, Jiang‐Tao Fu et al. · Theranostics · 2021 · 77 citations · Full text

Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation

Si-Jia Sun, Xiao‐Dong Jiao, Zhigang Chen et al. · Nature Communications · 2024 · 38 citations · Full text

P7C3‐A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21/FGF1, via the AMP‐activated protein kinase/CREB regulated transcription coactivator 2 pathway

Hua Xia, Di‐Yang Sun, Wenjie Zhang et al. · British Journal of Pharmacology · 2020 · 35 citations